Sun Yat-sen University cancer center, 651 Dongfeng Road east, Guangzhou, 510060, China.
State Key Laboratory of Oncology in Southern China, Guangzhou, China.
BMC Cancer. 2017 Dec 20;17(1):873. doi: 10.1186/s12885-017-3862-8.
BACKGROUND: Right-sided colon cancer (RCC) and left-sided colon cancer (LCC) differ with respect to their biology and genomic patterns, but inflammatory index variation did not fully investigate. This study aimed to examine the difference of inflammatory indexes and its value between RCC and LCC. METHODS: The differences of common clinicopathologic factors, inflammatory indexes including PLR (Platelet lymphocyte ratio) between LCC and RCC were analyzed in the training cohort with logistic regression model, subsequently, confirmed in validation cohort. Kaplan-Meier analysis was applied for the analysis of the survival difference distinguished by the PLR and the Nonparametric Test was adopted to demonstrate the difference of PLR variation with the standard TNM classification between RCC and LCC. RESULTS: A total of 1846 CRC patients entered the study, 744 (40.3%) patients were RCC, 1102 (59.7%) were LCC. The patients' number in both cohorts was 923. It was found that LCC patients in the training cohort significantly to be with higher CEA, adenocarcinoma, early UICC/AJCC stage, p-MMR (mismatch-repair proficient), and lower PLR, and the later four features were confirm in validation cohort. Higher PLR, the unique inflammatory index, was significantly associated with poorer OS in LCC cohort (P = 0.002) and was elevated with the TNM stage in the LCC patients (P < 0.001), however, the two relationships did not sustain in RCC patients. CONCLUSION: Expect the classical characteristics, PLR, an inexpensive and easily assessable inflammatory index was found first time to be significant differ between LCC and RCC. Further, elevated PLR associated with poor OS (overall survival) in the LCC and more common in advanced TNM stage.
背景:右半结肠癌(RCC)和左半结肠癌(LCC)在生物学和基因组模式上存在差异,但炎症指标的变化尚未得到充分研究。本研究旨在探讨炎症指标在 RCC 和 LCC 之间的差异及其价值。
方法:在训练队列中,使用逻辑回归模型分析 LCC 和 RCC 之间常见临床病理因素和炎症指标(包括血小板淋巴细胞比值[PLR])的差异,随后在验证队列中进行验证。采用 Kaplan-Meier 分析比较 PLR 区分的生存差异,采用非参数检验比较 RCC 和 LCC 中 PLR 变化与标准 TNM 分期的差异。
结果:共纳入 1846 例 CRC 患者,其中 744 例(40.3%)为 RCC,1102 例(59.7%)为 LCC。两个队列的患者数量均为 923 例。研究发现,训练队列中 LCC 患者的 CEA、腺癌、早期 UICC/AJCC 分期、p-MMR(错配修复功能正常)更高,PLR 更低,且后四个特征在验证队列中得到了验证。在 LCC 队列中,较高的 PLR(唯一的炎症指标)与较差的 OS 显著相关(P=0.002),并且在 LCC 患者中与 TNM 分期升高相关(P<0.001),但这两个关系在 RCC 患者中并不成立。
结论:除了经典特征外,PLR 是一种廉价且易于评估的炎症指标,首次发现其在 LCC 和 RCC 之间存在显著差异。此外,PLR 升高与 LCC 的 OS 不良(总体生存)相关,并且更常见于晚期 TNM 分期。
Zhonghua Wei Chang Wai Ke Za Zhi. 2024-6-25
World J Gastroenterol. 2024-9-7
World J Gastroenterol. 2015-6-7
Clin Colorectal Cancer. 2018-7-5
Cancer Cell Int. 2021-4-13
Clin Colorectal Cancer. 2016-6
Eur J Cancer Care (Engl). 2017-3